Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction.

导出 OA

翻译打印收藏纠错

作者： Gregory L,Snow ^[1] ; Joseph R,Bledsoe ^[2] ; Allison,Butler ^[3] ; Emily L,Wilson ^[1] ; Susan,Rea ^[4] ; Sarah,Majercik ^[5] ; Jeffrey L,Anderson ^[2] ; Benjamin D,Horne ^[6]

作者单位： Office of Research, Intermountain Healthcare, Salt Lake City, Utah, United States of America. ^[1] Emergency Department, Intermountain Medical Center, Salt Lake City, Utah, United States of America. ^[2] Department of Emergency Medicine, Stanford University School of Medicine, Stanford, California, United States of America. ^[3] Pulmonary and Critical Care Division, Department of Medicine, Intermountain Medical Center, Salt Lake City, Utah, United States of America. ^[4] Care Transformation, Intermountain Healthcare, Salt Lake City, Utah, United States of America. ^[5] Intermountain Medical Center Heart Institute, Salt Lake City, Utah, United States of America. ^[6] Cardiology Division, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, United States of America. ^[7] Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, United States of America. ^[8]